Achilles Therapeutics (ACHL)

1.39

0.01 (0.72%)

At close: Mar 03, 2025, 3:59 PM

1.38

-0.36%

After-hours: Mar 03, 2025, 04:50 PM EST

Achilles Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-69.94M	-71.18M	-61.1M	-33.2M	-13.99M	-6.89K
Depreciation & Amortization	4.71M	3.69M	3.29M	772K	302K	173.00
Stock-Based Compensation	6.36M	7.02M	6.32M	2.99M	719K	76.00
Other Working Capital	10.41M	-7.86M	-5.36M	-2.25M	-1.73M	-846
Other Non-Cash Items	7.03K	6.88M	-18K	1.18M	-9K	-114
Deferred Income Tax	n/a	n/a	159K	n/a	14K	n/a
Change in Working Capital	10.41M	-5.96M	-7.93M	3M	-1.18M	-846
Operating Cash Flow	-48.45M	-59.53M	-59.28M	-25.25M	-14.14M	-7.6K
Capital Expenditures	-1.1M	-7.51M	-7.63M	-11.85M	-942K	-258
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-7.51M	-7.63M	n/a	n/a	n/a
Investing Cash Flow	-1.1M	-7.51M	-7.63M	-11.85M	-942K	-258
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	34.88	n/a	160.75M	113.7M	93.23M	13.51K
Financial Cash Flow	9K	1K	160.75K	113.7M	93.62M	13.51K
Net Cash Flow	-41.8M	-92.98M	88.5M	80.25M	86.91M	5.7K
Free Cash Flow	-49.55M	-67.05M	-66.92M	-37.1M	-15.08M	-7.86K